Format

Send to

Choose Destination
Curr Opin Microbiol. 2018 Apr;42:31-39. doi: 10.1016/j.mib.2017.09.012. Epub 2017 Oct 16.

Immune cell type 'fingerprints' at the basis of outcome diversity of human infection.

Author information

1
Weizmann Institute of Science, Department of Biological Regulation, Rehovot, Israel.
2
Weizmann Institute of Science, Department of Biological Regulation, Rehovot, Israel. Electronic address: roi.avraham@weizmann.ac.il.

Abstract

Despite the availability of antibiotics and immunization, infectious diseases remain a major cause of malignancy and death worldwide. Yet, it is well documented that for most infectious agents, clinical disease develops in only a small minority of infected individuals. There is, in fact, great heterogeneity in infection outcome, from complete clearance of the pathogen to severe illness. Understanding this variation remains elusive, despite its great potential to equip us with new tools for the treatment of infectious diseases. Here, we propose a novel perspective for studying this diversity in human infection outcome, one that utilizes single-cell analysis technologies. Recent advances in single-cell RNA-seq technologies allow the detection of rare subpopulations that play important roles in host-pathogen interactions. We propose that applying single-cell RNA-seq to the study of infection can provide a 'fingerprint' of the immune cell types that are associated with the ability of the host to clear a pathogen and, thereby, broaden our current understanding of variation in susceptibility to infection within the population.

PMID:
29049916
DOI:
10.1016/j.mib.2017.09.012

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center